Dr. Pengfei Yu 俞鹏飞
Chief Physician
Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastric malignancies, including laparoscopic radical gastrectomy, function-preserving surgery for early gastric cancer, standard radical gastrectomy for advanced cases, and conversion therapy for late-stage gastric cancer.
Dr. Yu holds an MD from Zhejiang University School of Medicine and serves as a Chief Physician and Master’s Supervisor. A visiting scholar at the Japanese Foundation for Cancer Research Cancer Institute Hospital, Dr. Yu has published over 20 papers, including more than 10 SCI-indexed articles, and participates in multiple National Natural Science Foundation projects.
Professional roles
- Member, Editorial Board, World Journal of Gastrointestinal Surgery
- Member, International Gastric Cancer Association (IGCA)
- Youth Committee Member, Gastrointestinal Stromal Tumor Professional Committee, China Anti-Cancer Association
- Youth Committee Member, Tumor Gastroenterology Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Yu Pengfei). Papers usually list the name as Pengfei Yu or Yu P.
Selected publications
59 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): Mechanisms and functions of the TRIM protein family in digestive system cancers. PubMed 42919382
- Cell Commun Signal, 2025 (first author): Molecular and immune determinants of response in locally advanced deficient DNA mismatch repair/microsatellite instability-high gastric or gastroesophageal junction adenocarcinoma treated with neoadjuvant chemoimmunotherapy. PubMed 41469709
- BMC Gastroenterol, 2024 (senior author): Clinicopathological features and prognostic significance of TAF1L in gastric cancer. PubMed 39623292
- Genome Med, 2024 (first author): Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer. PubMed 38849905
- Int J Surg, 2024 (first author): Genomic and immune microenvironment features influencing chemoimmunotherapy response in gastric cancer with peritoneal metastasis: a retrospective cohort study. PubMed 38502852
- Nat Commun, 2024 (first author): Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment. PubMed 38704377
- Cancer Med, 2024 (senior author): Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis. PubMed 38457192
- Gastric Cancer, 2023 (senior author): SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score-matched analysis. PubMed 37768447
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion